AKT1 and glioblastoma: It is important to note that glioblastomas overexpressing Eph A2 are characterized by high activation of AKT which, in turn, phosphorylates EphA2 on S897, and converts EphA2 from a tumor suppressor to a pro-invasive oncogenic protein.